Optimising TCR T-Cell Therapy Manufacturing in Preparation for Late-Stage Clinical Development
Time: 11:30 am
day: Day 1 - Track C - AM
Details:
- IMA203 & IMA203CD8 are Immatics’ TCR-T product candidate(s) using a PRAME-specific TCR with or without a CD8 co-receptor
- Stepwise process development leading to increased manufacturing robustness and success rates
- Additional improvements have led to a significant reduction of vein-to-vein time
